Patent ID: 6806272
Filing Date: 2004-10-19
Classification: C07D

Abstract:
A compound of the formula (I), whereinR1 denotes a group selected from among hydrogen, NH2, XH, halogen and a C1-C3-alkyl group optionally substituted by one or more halogen atoms, R2 denotes a group selected from among hydrogen, CHO, XH, â€”Xâ€”C1-C2-alkyl and an optionally substituted C1-C3-alkyl group, R3, R4 are identical or different and denote a group selected from among optionally substituted C1-C10-alkyl, C2-C10-alkenyl, C2-C10-alkynyl, aryl, heteroaryl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, â€”Xâ€”aryl, â€”Xâ€”heteroaryl, â€”Xâ€”cycloalkyl, â€”Xâ€”heterocycloalkyl, â€”NR8-aryl, â€”NR8-heteroaryl, â€”NR8-cycloalkyl, and â€”NR8-heterocycloalkyl, or a group selected from among hydrogen, halogen, COXR8, CON(R8)2, COR8 and XR8, or R3 and R4 together denote a 2- to 5-membered alkyl bridge which may contain 1 to 2 heteroatoms, R5 denotes hydrogen or a group selected from among optionally substituted C1-C10-alkyl, C2C10-alkenyl, C2-C10-alkynyl, aryl, heteroaryl and â€”C3-C6-cycloalkyl, or R3 and R5 or R4 and R5 together denote a saturated or unsaturated C3-C4-alkyl bridge which may contain 1 to 2 heteroatoms, R6 denotes optionally substituted aryl or heteroaryl, R7 denotes hydrogen or â€”COâ€”Xâ€”C1-C4-alkyl, and X in each case independently of one another denotes O or S, and R8 in each case independently of one another denotes hydrogen or a group selected from among optionally substituted C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl and phenyl, or the tautomers, the racemates, the enantiomers, the diastereomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts thereof.